U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339176) titled 'Intratumoral N17350 in Advanced Solid Tumors' on Jan. 12.
Brief Summary: The goal of this clinical trial is to learn if N17350 works to treat advanced solid tumors in adults. It will also learn about the safety of N17350 and help determine the best dose to use in future studies.
The main questions it aims to answer are:
1. Does N17350 cause tumors to shrink or stop growing in some participants with advanced solid tumors?
2. Are there any side effects for participants when taking N17350?
3. What is the safest dose of N17350 and the dose that should be used for further study?
4. Researchers will give N17350 directly into tumor le...